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RThe ethics of innovation: Columbus and others try something newEMartin F. McKneally, MD, PhDWhen is it ethically acceptable to embark on an innovation
that involves the life and health of human subjects? Our au-
thors regularly submit new operations, devices, and man-
agement techniques for publication in the Journal.
Because professional journals and organizations are held
accountable for their implicit endorsement of off-label
and novel practices that prove to be dangerous or harmful,
Editor Larry Cohn asked me to comment on the ethics of in-
novation. I’ll begin and end with a case, describe an ethics
framework for innovation, and recommend a practical
approach that has served us well.
THE CASE
Christopher Columbus hypothesized that he could de-
velop a shorter trade route to India by sailing straight west
across the Atlantic. He was an experienced captain who
had exceptional knowledge of ocean currents and celestial
navigation. He had sailed as far west as the Canary Islands,
100 km off the west coast of Africa. During these innovative
excursions, he did not fall off the edge of the world or en-
counter the dragons depicted on maps of that era. The cur-
rents off the Canaries, where he was alleged to have kept
a mistress, ran westward toward an uncharted new world.
Should Columbus have told the sailors he recruited that
he was not planning to follow the navigational convention
of sailing down the coast of Africa and around the Cape
of Good Hope in constant sight of land? His seasoned col-
league Pinchon, the captain of the Ni~na, advised recruiting
seamen with the usual inducements—a good ship, good
captain, rum, and the prospect of shared treasure—without
mentioning the innovation of sailing an uncharted course. If
Columbus insisted on full disclosure, Pinchon recommen-
ded recruiting convicted prisoners with the promise of
a royal pardon if they survived. Columbus retired to a mon-
astery to seek consultation with the monks, pray for guid-
ance, and make a decision. What should Columbus do?
ETHICS FRAMEWORK
Ethics is a plural noun. An ethic is a set of values, princi-
ples, beliefs, and standards of conduct that guide the behav-
ior of a specified group, such as journalists, lawyers, orFrom the Department of Surgery and Joint Centre for Bioethics, University of
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The Journal of Thoracic and Cadoctors. The ethic of surgery, with its foundational values
of competence and commitment, is a singularly intense ver-
sion of the ethic of medicine. The magnitude of the viola-
tions of physical integrity and dignitary rights of surgical
patients1 and the immediacy of the surgeon’s personal en-
gagement and responsibility contribute to this singularity.
Surgeons take pains to explain in detail the goals, conse-
quences, and expected outcomes of the surgical interven-
tions they plan to perform. The variability of the terrain in
which we practice leads to inevitable unplanned innovation:
‘‘We couldn’t remove the tumor, but we were able to bypass
it,’’ or ‘‘We had only one donor lung, so we did a contralat-
eral volume reduction on the recipient to maximize func-
tion.’’2 Such innovations are morally justified in the court
of professional opinion by their reasonableness, the lack
of better alternatives, and their congruence with the values
and principles of the surgical community.
Planned innovations, like Columbus’ voyage, require
definition and forethought. Innovation is a notional concept.
There are many notions of its meaning, and no widely ac-
cepted definition. To distinguish innovation from the minor
incremental changes that surgeons introduce in the course
of everyday practice, we have defined surgical innovation
as ‘‘a new evolving intervention whose effects, side-
effects, safety, reliability and complications are not widely
known.’’3 This definition is intended to encompass transfor-
mative rather than incremental changes. Although the
boundary between minor incremental improvements and
major transformative innovations is difficult to define, it is
easy to recognize. McBurney’s decision to remove the ap-
pendix through a small, muscle-splitting incision trans-
formed the treatment of appendicitis. Prestigious
advocates of traditional management, including William
Osler, were adamantly opposed to his approach. McBurney
thought that the conventional treatment—hot packs to the
abdomen, morphine analgesia, turpentine enemas, rectal in-
sufflation of tobacco smoke, and eventual drainage of the
periappendicial abscess—was inadequate. Against the pre-
vailing beliefs of medical and surgical colleagues, he devel-
oped a bold new transformative treatment.
The guidance documents on the ethics of innovation are
reasonable but insufficient. For example, the Declaration
of Helsinki4 is the Journal’s reference standard; it autho-
rizes us to try unproven treatments when nothing else
works, to save life, re-establish health, or alleviate suffer-
ing. ‘‘In the treatment of a patient, where proven interven-
tions do not exist or have been ineffective, the physician,
after seeking expert advice, with informed consent from
the patient or a legally authorized representative, may use
an unproven intervention if in the physician’s judgment itrdiovascular Surgery c Volume 141, Number 4 863
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ing suffering. Where possible, this intervention should be
made the object of research designed to evaluate its safety
and efficacy. In all cases, new information should be re-
corded and, where appropriate, made publicly available.’’4
The problem with this principle is that it allows innovation
only where proven interventions do not exist or are ineffec-
tive. Innovations in areas that might make the treatment
cheaper, quicker, less debilitating, or easier to teach are ig-
nored. We innovate to improve interventions that are al-
ready in existence and effective but may be too expensive,
slow, uncomfortable, or inconvenient.
A thoughtful book, Ethical Guidelines for Innovative
Surgery,5 summarizing 5 years of study and 2 conferences
on surgical innovation, addresses some of these issues. It
will reward careful reading and provides a basis for further
research.
ETHICAL ISSUES SPECIFIC TO INNOVATIVE
SURGERY
An issue is an important social question to which there is
often more than one reasonable answer. The important
issues confronting innovators and those accountable for
innovations are consent, validity, competence, conflict of
interest, cost, and oversight.
Consent
The issue of consent is particularly sensitive and easily
mismanaged. In a progressive society, procedures that are
described as new are often presumed to be improvements
relative to those that are older. Patients subjected to un-
proven interventions should be explicitly informed about
the innovation’s novelty and lack of a proven record of ef-
fectiveness. Consent for the first patient to undergo heart
surgery with cross-circulation is well described in G.
Wayne Miller’s excellent book King of Hearts: The True
Story of the Maverick Who Pioneered Open Heart Surgery.6
‘‘The Gliddens remembered their daughter LaDonnah, who
had been born with the same [ventricular septal] defect..
They were willing to try almost anything to spare their
baby Gregory their daughter’s fate.’’6 In obtaining their con-
sent for a landmark innovative operation, ‘‘[Walt] Lillehei
told the Gliddens that his ‘‘artificial heart’’ was actually an-
other person—in fact, one of them. [He] drew a diagram of
cross-circulation and talked of his experimental success
with dogs.’’6 In contrast, many innovators are tempted to
take the easy and less transparent approach, saying simply,
‘‘We have a new [and, by implication, better] way to do your
operation.’’ Participants undergoing innovative interven-
tions should be informed of the novelty of the undertaking.
Validity
The issue of validity is less settled with innovation than
with accepted standard procedures, although many of the864 The Journal of Thoracic and Cardiovascular Surglatter remain unvalidated. Valid interventions are effective,
well-founded, and able to produce the desired result. The
word valid derives from the Latin validus, meaning strong.
An innovation may be presumed to be valid if it is founded
on reasonable evidence of feasibility and effectiveness. This
evidence may come from unplanned successful experience
in an emergency, studies in animals, or demonstrations in
the anatomy or pathology laboratory. Further support may
come from the experience and endorsement of peers work-
ing with similar frontier technologies and techniques. Intro-
duction of an innovation is ethically justified on the grounds
of probable validity, as judged by competent professionals.
This remains a claim until validating evidence has been de-
veloped with the help of well-informed, willing patients.
Successful application in their care provides the basis for
eventual recognition of the innovation as a validated com-
ponent of the surgical armamentarium.
Competence
A foundational element of the surgical ethic is compe-
tence to perform the appropriate surgical intervention
with a high probability of success and a low risk of compli-
cations. Many innovations challenge the competence of the
surgical team. The learning curve—the progression in
knowledge and skill in performance of innovative
procedures—should be managed collaboratively with col-
leagues under professional oversight.7 There is an addi-
tional issue of the impact on training. As teachers work
on mastering new techniques, such as robotic cardiac sur-
gery or video-assisted thoracic surgery, the operative expe-
rience of their residents and fellows is inhibited. In some
instances, gaining sufficient confidence to teach new proce-
dures can take a year or longer.
Conflicts of Interest
Conflicts of interest arise in ‘‘situation(s) in which an in-
terest (financial, personal, political) can interfere with
a duty.’’8 The financial, personal, or reputational interests
of innovative surgeons can compete with their fiduciary
duty to put patients’ interests first. The temptation to in-
crease market share, academic credit, or personal notoriety
may lead to overuse or less attention to the cost of new tech-
nology. Professional oversight can help to manage this risk.
Cost
The issue of cost arises because innovations in health care
have been linked to the rapid rise in the cost of health care,
potentially disadvantaging such other priorities as educa-
tion and highway safety. Technologic innovation is believed
to be responsible for the rise of the cost of health care at 2 to
3 times the rate of inflation. At hospitals emphasizing fron-
tier technologies, the rate may be substantially higher. This
conflict is an issue in societal justice, not simply a hospital
management problem.ery c April 2011
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The issue of oversight requires special consideration. Re-
sponsibility for ensuring that consent, validity, conflicts of in-
terest, and cost are managed correctly is a professional issue.
The chief of service and the institutional trustees are held
publicly accountable when innovations go awry. Although
some institutions delegate responsibility for oversight to in-
stitutional [ethics] review boards or research ethics boards,
innovation is not research. There is a family resemblance
between them, arising from their experimental nature.
Research is designed to produce generalizable knowl-
edge, with carefully controlled methods for patient selec-
tion and treatment assignment and with specified uniform
techniques and outcome measures. The conduct of research
is specified in predetermined, agreed, approved protocols to
minimize the effects of chance variables. In contrast, the
methods, patient selection, technical steps, and manage-
ment are constantly evolving during the development of
an innovative surgical procedure (Table 1). The innovators’
question is, ‘‘How can we make this work?’’ With time, pa-
tient selection, management approaches, instrument modifi-
cations, and techniques evolve. When all these have been
settled, formal research can be undertaken to test hypothe-
ses about the innovation, to answer the question, ‘‘Is this
better than the standard approach?’’.
Almost every major advance in medicine and surgery has
been introduced through the pathway of innovation. Anes-
thesia, antibiotics, arthroscopy, aneurysmectomy, and aortic
valve replacement exemplify only a few of the a’s. Innova-
tions can be hypothesis generating, but formal research to
compare the outcomes with conventional treatment follows
relatively rarely.
THE CASE REVISITED
Columbus did disclose his novel plan to the men he re-
cruited. Unlike Pinchon, he reasoned that they should not
all be thought of as identical members of a single category,
with identical attitudes toward risk. This wise decision gave
more risk-averse candidates, or those with pregnant wives
or aging parents, the opportunity to opt out of a heroic ad-
venture with unknown risks.
Rejection of Pinchon’s prisoner proposal may have saved
Columbus’s life. When the voyage stretched longer and lon-TABLE 1. Innovation versus research
Innovation Research
Techniques Evolving Defined
Outcome measures Evolving Defined
Patient selection Evolving Defined
Conclusions Tentative,
particular
Generalizable
Oversight Professional Societal (institutional
review board, research
ethics board)
The Journal of Thoracic and Cager and the crew became restless, some turned against the
captain, considering mutiny. If he had chosen criminals,
with their ingrained distrust of authority and advanced edu-
cation in violence, he might not have lived to celebrate his
discovery of Hispaniola and the new world.
HOW WE INTRODUCE SURGICAL
INTERVENTIONS
At several of the teaching hospitals at the University of
Toronto, a helpful ‘‘Enabling Innovation’’ protocol has
been in place for several years.9
1. The surgeon initiates an ‘‘Enabling Innovation Let-
ter’’ to the Surgeon-In-Chief (SIC), describing the in-
novative procedure or device, the rationale for the
request (including expected benefits, risks, and costs),
and the names of 2 informed colleagues who endorse
the validity of the proposal. These may be internal or
external advisors whom the SIC can consult if needed.
2. The surgeon pledges to add the ‘‘Columbus Clause’’ to
the standard consent form: ‘‘I understand that this treat-
ment is new to this hospital. I will be one of the first [x]
patients to receive it here. I have been offered the stan-
dard treatment. My doctors and nurses are working to
find the best way to perform the new treatment and
learn which patients will benefit most from it.’’
3. If needed, the SIC consults members of an unconv-
ened innovation task force of nursing, anesthesia, en-
gineering, ethics, and legal personnel who are
familiar with the Enabling Innovation pathway.
4. The SIC shows the letter and consent form to the chair
of the research ethics board, who accepts or advises
full review. This step proved useful in the early adop-
tion phase of the policy. The research ethics boards no
longer consider this necessary unless the SIC decides
it is appropriate.
5. The innovator reports the outcomes of the first patients
treated to theSIC,withhelp fromhospital datamanagers
and cost estimates from the operating room manager.
6. Formal research is initiated if and when appropriate.
Like Columbus’ sailors, patients are not identical mem-
bers of a single category with identical attitudes toward
risk. Some are intensely risk averse, some are foolishly ad-
venturous, and some are heroes who arewell suited to partic-
ipate in advancing the frontier of medical science. Because
the risks and outcomes of innovative surgical procedures
are not always predictable, it seems fair and responsible to
use more thorough procedures for disclosing the uncer-
tainties associated with innovative surgical interventions.
In summary, surgical innovations should be able to meet
ethical standards of appropriate consent (including disclo-
sure of their novelty), validity, competence, management
of the conflicts of interest that might encourage their over-
use, assessment of the impact of their cost on institutional orrdiovascular Surgery c Volume 141, Number 4 865
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validity, conflict of interest, and cost criteria are managed
correctly.
Bryce Taylor, Jacob Langer, John Wedge, and Randi Zlotnik-
Shaul contributed to the development of the Enabling Innovation
policy. Deborah McKneally made helpful revisions to the
manuscript.References
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